Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Biohaven Receives Favorable Ruling in the Trade Secret Misappropriation Lawsuit

Biohaven Receives Favorable Ruling in the Trade Secret Misappropriation Lawsuit

MT newswireMT newswire2026/08/25 21:23
05:23 PM EDT, 08/25/2026 (MT Newswires) -- Biohaven (BHVN) said late Tuesday that the US District Court for the District of Delaware ruled in favor of the company related to a trade secret misappropriation and breach of contract litigation against Avilar Therapeutics and RA Capital Management. The judgment, which confirmed that RA Capital and Avilar Therapeutics willfully misappropriated a trade secret developed at Yale University related to its "MODA" targeted protein degradation platform, formalized a $4 million award to the company and Yale, according to a statement. Biohaven did not immediately respond to a request for comment from MT Newswires.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Fed's Barkin Warns: Rising US Debt Will Eventually Face a "Reckoning"

Federal Reserve’s Barkin stated that the continuously rising US debt will eventually lead to a reckoning.

智通财经2026/08/25 23:51
Fed's Barkin Warns: Rising US Debt Will Eventually Face a "Reckoning"

Outlook remains moderate after product line expansion! Zoom (ZM.US) Q2 results exceeded expectations, but Q3 guidance failed to boost investor confidence

Zoom reported better-than-expected results for the second quarter of fiscal year 2027, but at the same time provided a somewhat subdued revenue outlook for the third quarter, disappointing investors who had hoped that the company's expanding product portfolio would drive greater growth.

智通财经2026/08/25 23:31
Outlook remains moderate after product line expansion! Zoom (ZM.US) Q2 results exceeded expectations, but Q3 guidance failed to boost investor confidence

JOYY (JOYY.US) Q2 revenue growth continues to accelerate, raises full-year operating profit forecast for 2026

JOYY's total revenue for the second quarter reached $590.8 million, representing a year-on-year increase of 16.3% and a quarter-on-quarter increase of 6.3%, achieving both annual and quarterly growth.

智通财经2026/08/25 23:21
JOYY (JOYY.US) Q2 revenue growth continues to accelerate, raises full-year operating profit forecast for 2026